IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Burrage Capital Management LLC

Q1 2021 Holdings

Filed 2021-05-17 | 27 holdings | $21.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$8.8M864,91641.0%
Cytokinetics Inc(CYTK)COM23282W605$5.7M244,67326.6%
Crinetics Pharmaceuticals in(CRNX)COM22663K107$4.2M272,39319.4%
Black Diamond Therapeutics I(BDTX)COM09203E105$2.7M110,44712.5%
Protalix Biotherapeutics Inc(PLX)COM74365A309$9.5K2,125,5850.0%
MEI Pharma IncCOM55279B202$8.0K2,331,3130.0%
PTC Therapeutics Inc(PTCT)COM69366J200$7.6K160,3720.0%
Neogenomics Inc(NEO)COM64049M209$7.1K147,9210.0%
Essa Pharma Inc(EPIEUR)COM NEW29668H708$6.9K237,4420.0%
Turning Point Therapeutics ICOM90041T108$6.8K72,1640.0%
Intellia Therapeutics Inc(NTLA)COM45826J105$5.1K63,6340.0%
Harmony Biosciences Hldgs in(HRMY)COM413197104$5.0K150,0000.0%
Epizyme Inc(EPZMEUR)COM29428V104$4.9K564,5550.0%
Mirum Pharmaceuticals Inc(MIRM)COM604749101$4.1K205,8660.0%
Cara Therapeutics Inc(CARAEUR)COM140755109$3.9K180,0000.0%
Fulcrum Therapeutics Inc(FULC)COM359616109$3.8K319,8190.0%
Tricida Inc(1T7)COM89610F101$3.5K658,8770.0%
Apellis Pharmaceuticals Inc(APLS)COM03753U106$3.5K80,7270.0%
Y-Mabs Therapeutics Inc(YMABUSD)COM984241109$3.5K114,4540.0%
Inozyme Pharma IncCOM45790W108$3.4K169,4730.0%
Avrobio IncCOM05455M100$3.1K244,9200.0%
ADC Therapeutics SA(ADCT)SHSH0036K147$3.0K124,8750.0%
Geron Corp(GERN)COM374163103$3.0K1,912,6730.0%
G1 Therapeutics Inc(GTHXEUR)COM3621LQ109$2.8K117,7080.0%
Merus N VCOMN5749R100$2.7K130,6830.0%
Turning Point Therapeutics IPUT90041T958$8617000.0%
Intellia Therapeutics IncPUT45826J955$466300.0%